This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
11/27/15 - 12:59:58 PM ET (BATS BZX Real-time Price)
Div Yield: --
KERX Day's Range
KERX 52 Week Range
KERX Business Summary
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States.View KERX key stats
Keryx Biopharmaceuticals Inc - KERX - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Keryx Biopharmaceuticals Inc as a
Sell with a ratings score of D-.
Report Snippet: We rate KERYX BIOPHARMACEUTICALS INC (KERX) a SELL. This is driven by some concerns, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, poor profit margins, weak operating cash flow and generally disappointing historical performance in the stock itself.